Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Exosomics Siena S.p.A.

The mission of Exosomics Siena S.p.A. is to develop, clinically validate and commercialize proprietary exosomes based cancer diagnostics and precision medicine tools. Exosomics Siena is focused on developing and commercializing revolutionary, biofluid-based diagnostic tools for cancer screening and liquid biopsy to significantly improve early cancer detection and to deliver personalized medicine approaches that are able to improve lives and healthcare sustainability. *

 

Period Start 2017-05-16 existent
Products Industry BIOTECH
  Industry 2 molecular diagnostics
Persons Person Chiesi, Antonio (HansaBioMed Life Sciences OÜ 201705 Managing Director + Exosomics Siena SpA 201705 CEO)
  Person 2 Mahdavi, Behzad (Ginkgo Bioworks 202209– SVP Biopharma Manufacturing + Life Science Tools before Catalent + Lonza)
     
Region Region Siena (SI)
  Country Italy
  Street 35 Strada del Petriccio e Belriguardo
  City 53100 Siena
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Lonza Group AG. (5/16/17). "Press Release: Lonza Invests to Develop Exosomes for Next-generation Life Science Applications". Basel.
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Exosomics Siena S.p.A.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top